Deep Track Capital, LP 13D/13G Filings for Crinetics Pharmaceuticals, Inc. (CRNX)

Deep Track Capital, LP 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
09:08 am
Purchase
2021-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
Deep Track Capital, LP1,900,000
4.000%
1,334increase
(+0.07%)
Filing